ロード中...
BRCA1/2 testing: therapeutic implications for breast cancer management
Testing for germline BRCA1/2 mutations has an established predictive role in breast cancer risk assessment. More recently, studies have also identified BRCA1/2 status as clinically relevant in the selection of therapy for patients already diagnosed with breast cancer. Emerging breast and ovarian can...
保存先:
| 出版年: | Br J Cancer |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6048046/ https://ncbi.nlm.nih.gov/pubmed/29867226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0127-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|